Literature DB >> 99420

Antagonistic interaction of rifampicin and trimethoprim.

R J Harvey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 99420     DOI: 10.1093/jac/4.4.315

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses.

Authors:  M N Ellis; D C Lobe; T Spector
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

2.  Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.

Authors:  E Yourassowsky; M P van der Linden; M J Lismont; F Crokaert
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

3.  Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus.

Authors:  D R Moorman; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

Review 4.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

5.  Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination.

Authors:  C W Norden; E Keleti
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

Review 6.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

7.  Double-disk synergy test for detection of synergistic effect between antibiotics against nosocomial strains of staphylococcus aureus.

Authors:  Rasool Soltani; Hossein Khalili; Fateme Shafiee
Journal:  J Res Pharm Pract       Date:  2012-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.